Skip to content
← Back to this collection

PUBLICATIONS · 28291393

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Jun 1
First author
André MPE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Jun 1;35(16):1760-1763. doi: 10.1200/JCO.2017.72.2611.
    note
    Source null
    related pmid
    28368671
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2017 Aug 20;35(24):2853-2854. doi: 10.1200/JCO.2017.74.0068.
    note
    Source null
    related pmid
    28682682
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2017 Aug 20;35(24):2850-2851. doi: 10.1200/JCO.2017.73.3816.
    note
    Source null
    related pmid
    28682684
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2017 Aug 20;35(24):2852. doi: 10.1200/JCO.2017.73.9839.
    note
    Source null
    related pmid
    28682685
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2017 Aug 20;35(24):2854-2855. doi: 10.1200/JCO.2017.74.0076.
    note
    Source null
    related pmid
    28682688
    relationship
    Comment in
  6. citation
    J Clin Oncol. 2017 Aug 20;35(24):2851-2852. doi: 10.1200/JCO.2017.73.8369.
    note
    Source null
    related pmid
    28682690
    relationship
    Comment in
  7. citation
    J Clin Oncol. 2017 Aug 20;35(24):2849-2850. doi: 10.1200/JCO.2017.73.3568.
    note
    Source null
    related pmid
    28682691
    relationship
    Comment in
  8. citation
    Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):12-17. doi: 10.1016/j.ijrobp.2020.02.635.
    note
    Source null
    related pmid
    32142868
    relationship
    Comment in

Authors and identifiers

  1. name
    André MPE
    type
    Author
  2. name
    Girinsky T
    type
    Author
  3. name
    Federico M
    type
    Author
  4. name
    Reman O
    type
    Author
  5. name
    Fortpied C
    type
    Author
  6. name
    Gotti M
    type
    Author
  7. name
    Casasnovas O
    type
    Author
  8. name
    Brice P
    type
    Author
  9. name
    van der Maazen R
    type
    Author
  10. name
    Re A
    type
    Author
  11. name
    Edeline V
    type
    Author
  12. name
    Fermé C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    André MPE
    type
    Author
  2. name
    Girinsky T
    type
    Author
  3. name
    Federico M
    type
    Author
  4. name
    Reman O
    type
    Author
  5. name
    Fortpied C
    type
    Author
  6. name
    Gotti M
    type
    Author
  7. name
    Casasnovas O
    type
    Author
  8. name
    Brice P
    type
    Author
  9. name
    van der Maazen R
    type
    Author
  10. name
    Re A
    type
    Author
  11. name
    Edeline V
    type
    Author
  12. name
    Fermé C
    type
    Author
bibliography ids
  1. nci-bib-3ac31908f528a79fbcd3f52c
book metadata
content sha256
f68207bdf50ea790ed9394482a720309c47808c6611e8ab7742f1c38219b9ca0
document type
citation
dois
  1. 10.1200/JCO.2016.68.6394
electronic publication date
display
2017 Mar 14
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28291393
immutable id
pubmed:28291393@f68207bdf50ea790ed9394482a720309c47808c6611e8ab7742f1c38219b9ca0
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
16
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1786-1794
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Jun 1;35(16):1760-1763. doi: 10.1200/JCO.2017.72.2611.
    note
    Source null
    related pmid
    28368671
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2017 Aug 20;35(24):2853-2854. doi: 10.1200/JCO.2017.74.0068.
    note
    Source null
    related pmid
    28682682
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2017 Aug 20;35(24):2850-2851. doi: 10.1200/JCO.2017.73.3816.
    note
    Source null
    related pmid
    28682684
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2017 Aug 20;35(24):2852. doi: 10.1200/JCO.2017.73.9839.
    note
    Source null
    related pmid
    28682685
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2017 Aug 20;35(24):2854-2855. doi: 10.1200/JCO.2017.74.0076.
    note
    Source null
    related pmid
    28682688
    relationship
    Comment in
  6. citation
    J Clin Oncol. 2017 Aug 20;35(24):2851-2852. doi: 10.1200/JCO.2017.73.8369.
    note
    Source null
    related pmid
    28682690
    relationship
    Comment in
  7. citation
    J Clin Oncol. 2017 Aug 20;35(24):2849-2850. doi: 10.1200/JCO.2017.73.3568.
    note
    Source null
    related pmid
    28682691
    relationship
    Comment in
  8. citation
    Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):12-17. doi: 10.1016/j.ijrobp.2020.02.635.
    note
    Source null
    related pmid
    32142868
    relationship
    Comment in
outcomes validated
false
pmid
28291393
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
40b5686cdab36ea9d8584b44ad266a4ca897b31fb7e24db45a05a82d6356d7cf
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Jun 1
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28291393/
title
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

Preserved source evidence · Not medical advice